Danny L. Dearen - 20 May 2021 Form 4 Insider Report for Axonics, Inc.

Role
Officer
Signature
/s/ Danny L. Dearen
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
-$2,310,637
Form type
4
Filing time
24 May 2021, 20:45:53 UTC
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $401,449 +28,291 +283% $14.19* 38,291 20 May 2021 Direct
transaction AXNX Common Stock Options Exercise $12,805 +9,701 +25% $1.32* 47,992 20 May 2021 Direct
transaction AXNX Common Stock Options Exercise $6,787 +5,142 +11% $1.32* 53,134 20 May 2021 Direct
transaction AXNX Common Stock Sale $1,008,265 -18,516 -35% $54.45 34,618 20 May 2021 Direct F1, F2
transaction AXNX Common Stock Sale $1,355,135 -24,618 -71% $55.05 10,000 20 May 2021 Direct F1, F3
transaction AXNX Common Stock Options Exercise $1,308 +991 +9.9% $1.32* 10,991 21 May 2021 Direct
transaction AXNX Common Stock Options Exercise $9,576 +5,875 +53% $1.63* 16,866 21 May 2021 Direct
transaction AXNX Common Stock Sale $379,164 -6,866 -41% $55.22 10,000 21 May 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -28,291 -31% $0.000000 63,273 20 May 2021 Common Stock 28,291 $14.19 Direct F5
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -9,701 -86% $0.000000 1,616 20 May 2021 Common Stock 9,701 $1.32 Direct F6
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -5,142 -30% $0.000000 11,925 20 May 2021 Common Stock 5,142 $1.32 Direct F7
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -991 -8.3% $0.000000 10,934 21 May 2021 Common Stock 991 $1.32 Direct F7
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -5,875 -17% $0.000000 28,921 21 May 2021 Common Stock 5,875 $1.63 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $53.83 to $54.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $54.855 to $55.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $55.00 to $55.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
F6 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F7 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F8 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.